Tagged: keytruda

Is Keytruda cost-effective? - Public Health Expert

Public Health Expert Dec 15, 2015

Professor Tony Blakely Keytruda, or Pembrolizumab, is a new immune inhibitor drug that appears to have pronounced effectiveness in slowing – even reversing – disease progression in patients with advanced melanoma. It has received much media attention in recent months, and even calls from politicians to over-rule the PHARMAC process (currently PHARMAC do not recommend funding). In this blog … Read More